Home > Healthcare > Medical Devices > Therapeutic Devices > Continuous Renal Replacement Therapy Market
Continuous Renal Replacement Therapy Market size was worth more than USD 1 billion in 2022 and is estimated to witness robust growth at 6.9% CAGR from 2023 to 2032 attributed to the rising incidences of chronic renal diseases. As per recent data from 2022, chronic kidney diseases (CKD) is projected to impact 9.1% to 13.4% of the global population.
The growing episodes of kidney disorders can be attributed to unhealthy lifestyles as well as the increasing prevalence of diabetes, hypertension, and other comorbidities. According to the CDC, 37.3 million Americans, or 11.3% of the population suffered from diabetes in 2022. Furthermore, the presence of rapidly expanding geriatric population base worldwide vulnerable to renal illnesses has surged the demand for CRRT treatments. Moreover, the rising demand for advanced CRRT equipment and procedures in clinical settings to offer higher effectiveness, safety, and convenience of use will add to the market expansion.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Continuous Renal Replacement Therapy Market Size in 2022: | USD 1.1 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 6.9% |
2032 Value Projection: | USD 2.2 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 160 |
Tables, Charts & Figures: | 361 |
Segments covered: | Modality, Product, Therapy, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
The operational challenges associated with CRRT treatment methods may pose as a restraint for the market growth. To operate and manage the equipment efficiently, CRRT requires specialized training and technical knowledge. Increasing errors in machine setup, parameter modifications, or patient management leading to complications along with the shortage of qualified workers may also slow down the market growth.